KaydedilenlerDerginizi ekleyin

Dergiler / Business and Economics Research Journal / 2018 / Cilt: 9 - Sayı: 3

Market Structure of the Turkish Pharmaceutical Industry

EGEMEN İPEK
Ozlem IPEK
Sayfa
449–462
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition,the Rosenbluth index presents the most consistent results for the Turkishpharmaceutical sector, which consists of hundreds of small companies having marketsshares of 7% at the highest.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The market structure of the Pharmaceutical Industry, which has an extremelyimportant both socially and economically position, is carefully monitored by regulatoryauthorities.
📊
Temel Bulgular & Veri:For these reasons,in this study the market concentration ratios of the pharmaceutical sector in Turkey arecalculated by using concentration measures such as Concentration Ratio; HerfindahlHirschman; Hall-Tideman; Rosenbluth; Comprehensive Industrial Concentration;Hannah-Kay; Hause and the Entropy measure with the annual sales revenue data of thecompanies in the sector for the 2009-2016 period.According to the results,pharmaceutical sector in Turkey has a low concentrated market structure.
💡
Sonuç & Katkı:In addition,the Rosenbluth index presents the most consistent results for the Turkishpharmaceutical sector, which consists of hundreds of small companies having marketsshares of 7% at the highest.
🔬Tür:Araştırma Makalesi
📍Kapsam:2009-2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

The market structure of the Pharmaceutical Industry, which has an extremelyimportant both socially and economically position, is carefully monitored by regulatoryauthorities. The consantration of pharmaceutical companies tends to adversely affectconsumer welfare as well as resource distribution in the economy. The competitivestructure of the markets is determined by the concentration indices. For these reasons,in this study the market concentration ratios of the pharmaceutical sector in Turkey arecalculated by using concentration measures such as Concentration Ratio; HerfindahlHirschman; Hall-Tideman; Rosenbluth; Comprehensive Industrial Concentration;Hannah-Kay; Hause and the Entropy measure with the annual sales revenue data of thecompanies in the sector for the 2009-2016 period.According to the results,pharmaceutical sector in Turkey has a low concentrated market structure. In addition,the Rosenbluth index presents the most consistent results for the Turkishpharmaceutical sector, which consists of hundreds of small companies having marketsshares of 7% at the highest.

🔖

Bu Makaleye Atıf Yap

İPEK, E., IPEK, O. (2018). Market Structure of the Turkish Pharmaceutical Industry. Business and Economics Research Journal, Cilt: 9 - Sayı: 3, 449–462. https://ajindex.com/articles/352158

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Araştırmacı İlaç Firmaları Derneği (AIFD) (2012). Türkiye ilaç sektörü vizyon 2023 raporu. Bain, J. S. (1959). Industrial organization. New York: John Wiley & Sons Press.
  2. Balili, L. (2016). Analyzing competition in pharmaceutical sector–with a case study of Albania. European Scientific Journal, 12(15),132-142.
  3. Bikker, J. A., & Haaf, K. (2002). Measures of competition and concentration in the banking industry: A review of the literature. Economic & Financial Modelling, 9(2): 53-98.
  4. Chen, L., & Huaizhou, T. (2001). The study of market concentration of pharmaceutical industry in China. China Pharmacy, 1, 001-012.
  5. Davies, S. (1979). Choosing between Concentration Indices: The iso-concentration curve. Economica, 46(181),67-75. Doi:10.2307/2553097 De Vany, A,. & Kim, C. L. H. (2003). Stochastic market structure: Concentration measures and motion picture antitrust. No. 30701. University of Manchester, Institute for Development Policy and Management (IDPM). Finkelstein, M. O., & Friedberg, R. M. (1967). The application of an entropy theory of concentration to the Clayton Act. The Yale Law Journal, 76(4), 677-717.
  6. Fiuza, E. PS, & Lisboa, M.de B. (2003). Credence goods and market power: An econometric study on the Brazilian pharmaceutical industry. Estudos Econômicos, 33(4), 601-638.
  7. Grabowski, H. G., & Vernon, J. M. (1976). Structural effects of regulation on innovation in the ethical drug industry. Essays on industrial organization, in honor of Joe S. Bain. Hall, M., & Tideman, N. (1967). Measures of concentration. Journal of the American Statistical Association, 62(317), 162- 168. Hannah, L., & Kay, J. A. (1977). Concentration in modern industry: Theory, measurement and the UK experience. Springer. Hart, P.E. (1971). Entropy and other measures of concentration, Journal of the Royal Statistical Society, 134, 73-85.
  8. Hause, J. C. (1977). The measurement of concentrated industrial structure and the size distribution of firms. Annals of Economic and Social Measurement, 6(1), 73-107.
  9. Hennessy, D. A., & Lapan, H. (2007). When different market concentration indices agree. Economics Letters, 95(2), 234- 240. Horvath, J. (1970). Suggestion for a comprehensive measure of concentration. Southern Economic Journal, 36(4), 446- 452. Jacquemin, A. (1987). The new industrial organization. Cambridge, Mass.: MIT Press.
  10. Jacquemin, A. P., & Phlips, L. (1976). Concentration, size and performance of European firms. In Markets, corporate behaviour and the state, 55-77.
  11. Boston, MA: Sprin